O Brien Wealth Partners LLC Decreases Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)

O Brien Wealth Partners LLC lowered its position in LifeStance Health Group, Inc. (NASDAQ:LFST) by 11.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 316,371 shares of the company’s stock after selling 40,000 shares during the quarter. LifeStance Health Group comprises 0.4% of O Brien Wealth Partners LLC’s investment portfolio, making the stock its 21st largest holding. O Brien Wealth Partners LLC owned approximately 0.08% of LifeStance Health Group worth $2,215,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. SG Americas Securities LLC grew its holdings in LifeStance Health Group by 406.4% during the 3rd quarter. SG Americas Securities LLC now owns 54,532 shares of the company’s stock valued at $382,000 after buying an additional 43,763 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in LifeStance Health Group during the 2nd quarter valued at about $4,326,000. Algert Global LLC purchased a new position in LifeStance Health Group during the 2nd quarter valued at about $57,000. Sculptor Capital LP purchased a new position in LifeStance Health Group during the 2nd quarter valued at about $334,000. Finally, The Manufacturers Life Insurance Company grew its holdings in LifeStance Health Group by 14.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 73,943 shares of the company’s stock valued at $363,000 after buying an additional 9,156 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on LFST shares. UBS Group reduced their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a report on Thursday, August 15th. Barclays reduced their target price on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a report on Friday, August 9th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $8.25.

Insider Buying and Selling

In related news, insider Ann Varanakis sold 5,269 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the completion of the sale, the insider now owns 263,007 shares in the company, valued at $1,651,683.96. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 6.60% of the stock is currently owned by corporate insiders.

LifeStance Health Group Stock Performance

Shares of LFST opened at $6.85 on Friday. The company has a market cap of $2.62 billion, a PE ratio of -16.71 and a beta of 1.24. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.20. The stock has a 50-day moving average price of $6.75 and a 200-day moving average price of $6.13. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $9.20.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The firm had revenue of $312.30 million during the quarter, compared to the consensus estimate of $305.85 million. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. The company’s revenue for the quarter was up 20.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.13) EPS. As a group, equities analysts forecast that LifeStance Health Group, Inc. will post -0.24 earnings per share for the current fiscal year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.